WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 13th Annual BIO CEO & Investor Conference at The Waldorf=Astoria in New York City on Tuesday, February 15, 2011 at 10:00 a.m. Eastern Time.
